35
Participants
Start Date
September 1, 2025
Primary Completion Date
August 31, 2028
Study Completion Date
December 31, 2028
Haloperidol
The oral investigational agent haloperidol (Generic Brand: TEVA-HALOPERIDOL) will be self-administered, at night, over 7 days. Haloperidol will be titrated up to 2 mg.
Placebo
Oral placebo, encapsulated and to be taken at an equivalent titration schedule to Haloperidol.
Insulin Lispro
A total of 160 IU of intransal insulin (=1.6 mL) will be administered on MRI scanning visits (80 IU = 0.8 mL delivered per nostril). Humalog; Eli Lilly Canada
Saline
A total of 1.6 mL of intranasal saline will be administered on each MRI scanning visit (0.8 mL delivered per nostril).
Centre for Addiction and Mental Health, Toronto
The Physicians' Services Incorporated Foundation
OTHER
Centre for Addiction and Mental Health
OTHER